Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3

scientific article

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0161-6420(00)00409-7
P3181OpenCitations bibliographic resource ID608257
P932PMC publication ID1470467
P698PubMed publication ID11097601

P2860cites workSunlight and age-related macular degeneration. The Beaver Dam Eye StudyQ70655027
Lens Opacities and Senile MaculopathyQ70786046
Risk factors of age-related maculopathy in a population 70 years of age or olderQ71108625
A prospective study of cigarette smoking and age-related macular degeneration in womenQ71582100
Age-related macular degeneration is associated with atherosclerosis. The Rotterdam StudyQ71933360
The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye StudyQ73043468
Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study GroupQ73440318
Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey IIIQ77872867
Senile macular changes in the black AfricanQ33650851
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study GroupQ34323879
The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.Q34655539
Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination SurveyQ36455838
Ocular exposure to UV-B in sunlight: the Melbourne visual impairment project modelQ36795135
Preventative ophthalmology. Age-related macular degenerationQ36853154
The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart StudyQ39820430
Antioxidants and age-related eye disease. Current and future perspectivesQ40960608
Epidemiology of age-related maculopathy.Q41001245
The Wisconsin age-related maculopathy grading systemQ41902806
Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye SurveyQ43587787
Exposure to sunlight and other risk factors for age-related macular degenerationQ43660920
Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman studyQ44040811
The relationship of ocular factors to the incidence and progression of age-related maculopathyQ44412742
The Beaver Dam Eye Study: the relation of age-related maculopathy to smokingQ44551202
Smoking and age-related maculopathy. The Blue Mountains Eye StudyQ44591252
The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study.Q44975780
Features of age-related macular degeneration in a black population. The Barbados Eye Study GroupQ46246780
Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study GroupQ46603963
Cataract and age-related maculopathy: the Blue Mountains Eye Study.Q50516063
Refractive error and age-related maculopathy: the Blue Mountains Eye Study.Q50522416
Sample sizes for prevention trials have been too small.Q50698054
The long-term effects of visible light on the eye.Q50796491
Smoking and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Age.Q50869184
Senile macular degeneration: a case-control study.Q50927753
Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration.Q50992620
Are antioxidants or supplements protective for age-related macular degeneration?Q51596706
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study GroupQ56534843
Senile disciform macular degeneration and smokingQ67325346
Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study GroupQ67803483
The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levelsQ68090477
Prevalence of age-related maculopathy. The Beaver Dam Eye StudyQ68207448
Assessment of cataracts from photographs in the Beaver Dam Eye StudyQ68627070
Senile cataract and senile macular degeneration: an investigation into possible risk factorsQ68810230
Risk factors in age-related maculopathy complicated by choroidal neovascularizationQ68966862
Age-related macular degenerationQ69037879
The association of age-related macular degeneration and lens opacities in the agedQ69624187
Systemic hypertension and age-related maculopathy in the Framingham StudyQ70011828
Senile macular degeneration: a preliminary studyQ70470159
Essential fatty acids, plasma cholesterol, and fat-soluble vitamins in subjects with age-related maculopathy and matched control subjectsQ70574111
P433issue12
P407language of work or nameEnglishQ1860
P921main subjecteye diseaseQ3041498
P304page(s)2224-32
P577publication date2000-12-01
P1433published inOphthalmologyQ7098109
P1476titleRisk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3
P478volume107

Reverse relations

cites work (P2860)
Q33740158A Review of Current and Future Management of Geographic Atrophy
Q92301614A Review of Pathogenic Drivers of Age-Related Macular Degeneration, Beyond Complement, with a Focus on Potential Endpoints for Testing Therapeutic Interventions in Preclinical Studies
Q56243468A comparison of risk factors for age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese patients
Q34639285A genome-wide association study for primary open angle glaucoma and macular degeneration reveals novel Loci
Q24806062A randomised controlled trial investigating the effect of nutritional supplementation on visual function in normal, and age-related macular disease affected eyes: design and methodology [ISRCTN78467674]
Q24544001A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
Q39618688A suggested association between hypothyroidism and age-related macular degeneration
Q92523288A systematic approach to evaluate practice-based process- and outcome data applied to the treatment of neovascular age-related macular degeneration
Q26744106AMD and the alternative complement pathway: genetics and functional implications
Q43292216ARMS2/HTRA1 and CFH polymorphisms are not associated with choroidal neovascularization in highly myopic eyes of the elderly Japanese population
Q42492505Absence of collagen XVIII in mice causes age-related insufficiency in retinal pigment epithelium proteostasis
Q34551595Accelerated 20-year sunlight exposure simulation of a photochromic foldable intraocular lens in a rabbit model
Q45017248Accumulation of lipid particles in Bruch's membrane of LDL receptor knockout mice as a model of age-related macular degeneration
Q35983639Activation of the ERK 1/2 and STAT3 signaling pathways is required for 661W cell survival following oxidant injury
Q35126587Activation of the UPR protects against cigarette smoke-induced RPE apoptosis through up-regulation of Nrf2.
Q57480658Activator protein-1 contributes to the NaCl-induced expression of VEGF and PlGF in RPE cells
Q47427948Advances in Age-related Macular Degeneration Understanding and Therapy
Q42565175Advances in technology helps in early detection of vision disorders
Q24679626Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight
Q91840317Age-Related Macular Degeneration in Primary Osteoarthritis Egyptian Patients
Q26799617Age-Related Macular Degeneration: Advances in Management and Diagnosis
Q35126780Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies
Q81372969Age-related macular degeneration
Q82698020Age-related macular degeneration
Q34389315Age-related macular degeneration and risk of stroke
Q43252791Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes
Q31048292Age-related macular degeneration: epidemiology and optimal treatment
Q28506396Age-related retinal degeneration (arrd2) in a novel mouse model due to a nonsense mutation in the Mdm1 gene
Q37315838Aging is not a disease: distinguishing age-related macular degeneration from aging
Q51916228An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment.
Q35855800An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation.
Q36056865An association between environmental factors and the IVS4+44C>A polymorphism of the DMT1 gene in age-related macular degeneration
Q36747203An update on the genetics of age-related macular degeneration.
Q35690507Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration
Q24544270Analysis of Hemicentin-1, hOgg1, and E-selectin single nucleotide polymorphisms in age-related macular degeneration
Q51759447Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD).
Q34251889Angiotensin II-related hypertension and eye diseases
Q34295974Antiangiogenic therapy for ischemic retinopathies
Q24245483Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration
Q35749021Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy
Q40019102Asian age-related macular degeneration phenotyping study: rationale, design and protocol of a prospective cohort study
Q37612368Aspirin and age related macular degeneration; the possible relationship
Q34630065Aspirin use and risk of age-related macular degeneration: a meta-analysis
Q35762418Associated factors for age related maculopathy in the adult population in China: the Beijing eye study
Q33604743Association between Asymptomatic Unilateral Internal Carotid Artery Stenosis and Electrophysiological Function of the Retina and Optic Nerve.
Q39963674Association between asymmetry in cataract and asymmetry in age-related macular degeneration. The Beijing Eye Study
Q35737410Association between various types of obesity and macular pigment optical density.
Q92524759Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39
Q64111269Association of HTRA1 and ARMS2 gene polymorphisms with response to intravitreal ranibizumab among neovascular age-related macular degenerative subjects
Q43268210Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese women
Q35429130Association of OCT derived drusen measurements with AMD associated-genotypic SNPs in Amish population
Q57141419Association of obesity and age-related macular degeneration in Indian population
Q33584512Association of risk factors for choroidal neovascularization in age-related macular degeneration with decreased foveolar choroidal circulation
Q57539245Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population
Q34366242Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration
Q46831464Australian prospective study of cataract surgery and age-related macular degeneration: rationale and methodology
Q61804560Axial length and its associations in a Russian population: The Ural Eye and Medical Study
Q42359940Axial length and subfoveal choroidal thickness in individuals with age-related macular degeneration
Q39014462Benefits, Potential Harms, and Optimal Use of Nutritional Supplementation for Preventing Progression of Age-Related Macular Degeneration
Q45935732Brimonidine Can Prevent In Vitro Hydroquinone Damage on Retinal Pigment Epithelium Cells and Retinal Müller Cells.
Q37996128CFB/C2 gene polymorphisms and risk of age-related macular degeneration: a systematic review and meta-analysis.
Q35140894CFH, VEGF, and PEDF genotypes and the response to intravitreous injection of bevacizumab for the treatment of age-related macular degeneration
Q33616519Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study
Q36516001Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study
Q38716245Care of Older Adults: Role of Primary Care Physicians in the Treatment of Cataracts and Macular Degeneration.
Q38767261Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases
Q49222689Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study.
Q58737788Choriocapillaris changes in dry age-related macular degeneration and geographic atrophy: a review
Q35005946Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration
Q34930298Clinical characteristics and current treatment of age-related macular degeneration
Q36274578Clinical phenotypes associated with the complement factor H Y402H variant in age-related macular degeneration
Q34437319Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
Q41494023Comparison of clinical features and 3-month treatment response among three different choroidal thickness groups in polypoidal choroidal vasculopathy
Q39719940Comparison of stereoscopic digital imaging and slide film photography in the identification of macular degeneration.
Q98613384Comparison of the Morphology of the Foveal Pit Between African and Caucasian Populations
Q35133725Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium
Q54392848Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration.
Q24553334Complement factor H polymorphism in age-related macular degeneration
Q37626363Complement-associated deposits in the human retina
Q92132455Comprehensive expression patterns of inflammatory cytokines in aqueous humor of patients with neovascular age-related macular degeneration
Q54317190Contribution of the Nurses' Health Study to the Epidemiology of Cataract, Age-Related Macular Degeneration, and Glaucoma.
Q33507197Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach
Q28732075Copy number variation of age-related macular degeneration relevant genes in the Korean population
Q91045147Correlation of axial length and myopic macular degeneration to levels of molecular factors in the aqueous
Q37879172Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures
Q36841141Current smoking is associated with a poor visual acuity improvement after intravitreal ranibizumab therapy in patients with exudative age-related macular degeneration
Q36218094DETECTION OF NONEXUDATIVE CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Q36364712Daytime presentations to a metropolitan ophthalmic emergency department.
Q35908535Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration
Q37566563Dietary and lifestyle risk factors associated with age-related macular degeneration: a hospital based study
Q80941948Differences in reading performance of patients with Drusen maculopathy and subretinal fibrosis after CNV
Q38189104Does long-term aspirin use increase the risk of neovascular age-related macular degeneration?
Q36313773Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years.
Q34378033Dry age-related macular degeneration: A currently unmet clinical need
Q35857083Effect of High-Density Lipoprotein Metabolic Pathway Gene Variations and Risk Factors on Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy in China
Q35918965Effect of aspirin on models of retinal pigment epithelium pathology
Q33234332Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration
Q91584129Effects of Lutein Supplementation in Japanese Patients with Unilateral Age-Related Macular Degeneration: The Sakai Lutein Study
Q33773175Effects of bevacizumab on endoplasmic reticulum stress in hypoxic retinal pigment epithelial cells
Q46259787Effects of ginkgo biloba extract on cultured human retinal pigment epithelial cells under chemical hypoxia
Q60054053Effects of senescent secretory phenotype acquisition on human retinal pigment epithelial stem cells
Q40615188Epidemiology of age-related macular degeneration
Q30239897Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors
Q35560422Epidemiology of age-related maculopathy: a review
Q36124940Erp29 Attenuates Cigarette Smoke Extract-Induced Endoplasmic Reticulum Stress and Mitigates Tight Junction Damage in Retinal Pigment Epithelial Cells
Q37065197Estimated prevalence and risk factor for age-related maculopathy
Q90291055Evaluation of Peripheral Retinal Changes on Ultra-Widefield Fundus Autofluorescence Images of Patients with Age-Related Macular Degeneration
Q58602996Evaluation of the Relationship Between Age-related Macular Degeneration and Refractive Error, Socio-demographic Features, and Biochemical Variables in a Turkish Population
Q55190215Evidence for an Association between Macular Degeneration and Thyroid Cancer in the Aged Population.
Q43083299Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice
Q37187115Eye Care Disparities and Health-Related Consequences in Elderly Patients with Age-Related Eye Disease
Q36205759Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study
Q56555464Fluorescein Angiography Does Not Alter the Initial Clinical Management of Choroidal Neovascularization in Age-Related Macular Degeneration
Q89440936Food groups and risk of age-related macular degeneration: a systematic review with meta-analysis
Q97692887Functional imaging of mitochondria in retinal diseases using flavoprotein fluorescence
Q36467703Functional single nucleotide polymorphism in IL-17A 3' untranslated region is targeted by miR-4480 in vitro and may be associated with age-related macular degeneration
Q48346190Gender Differences in the Relationship between Sex Hormone Deficiency and Soft Drusen
Q47105600Genetic association study of age-related macular degeneration in the Spanish population
Q28396822Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study
Q37901276Genetic factors associated with age-related macular degeneration
Q28943491Genetic factors in nonsmokers with age-related macular degeneration revealed through genome-wide gene-environment interaction analysis
Q35749765Genetic factors of age-related macular degeneration
Q36732124Genome-wide analysis of copy number variants in age-related macular degeneration
Q36031664Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration
Q92886662Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Late-stage Age-Related Macular Degeneration
Q54990705Gonadal Hormones and Retinal Disorders: A Review.
Q57176321Gout and the risk of age-related macular degeneration in the elderly
Q33307521Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration
Q38807163Heritability of Choroidal Thickness in the Amish.
Q35761771High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture
Q98563377Home Monitoring of Age-Related Macular Degeneration: Real-World Utility of the ForeseeHome Device for Detection of Neovascularization
Q90598579Hypertension, antihypertensive medications use and risk of age-related macular degeneration in California Teachers Cohort
Q37265929Identification of a rare coding variant in complement 3 associated with age-related macular degeneration
Q33935415Identifying subtypes of patients with neovascular age-related macular degeneration by genotypic and cardiovascular risk characteristics.
Q64065229Impact of systemic vascular risk factors on the choriocapillaris using optical coherence tomography angiography in patients with systemic hypertension
Q44924511Impact of visual impairment on service and device use by individuals with age-related macular degeneration (AMD).
Q33848714In-depth analyses unveil the association and possible functional involvement of novel RAD51B polymorphisms in age-related macular degeneration
Q34114772Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis
Q37186026Influence of TIMP3/SYN3 polymorphisms on the phenotypic presentation of age-related macular degeneration
Q92609620Inhibition of thyroid hormone signaling protects retinal pigment epithelium and photoreceptors from cell death in a mouse model of age-related macular degeneration
Q37526810Intake of dietary salt and drinking water: Implications for the development of age-related macular degeneration
Q24246549Interferon alfa therapy for age-related macular degeneration
Q35095517Intracameral interleukin 1β, 6, 8, 10, 12p, tumor necrosis factor α and vascular endothelial growth factor and axial length in patients with cataract
Q48216065Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor
Q36925652Intravitreal ranibizumab and bevacizumab: a review of risk
Q33844950Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms
Q52359171Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci.
Q37206264Is age-related macular degeneration associated with stroke among elderly americans?
Q55003687KUS121, an ATP regulator, mitigates chorioretinal pathologies in animal models of age-related macular degeneration.
Q32125469LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis
Q35000314Light filtering in a retinal pigment epithelial cell culture model
Q37011339Lipid metabolites in the pathogenesis and treatment of neovascular eye disease
Q58715760Low incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD
Q43833541Lutein and zeaxanthin for macular degeneration
Q41111119Lutein and zeaxanthin isomers modulates lipid metabolism and the inflammatory state of retina in obesity-induced high-fat diet rodent model.
Q45233235MEF2D haploinsufficiency downregulates the NRF2 pathway and renders photoreceptors susceptible to light-induced oxidative stress.
Q43007001Macular degeneration associated with a novel Treacher Collins tcof1 mutation and evaluation of this mutation in age related macular degeneration.
Q104064473Macular retinal thickness differs markedly in age-related macular degeneration driven by risk polymorphisms on chromosomes 1 and 10
Q37349992Macular zeaxanthins and lutein -- a review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease
Q48622797Magnification-corrected photodynamic therapy.
Q91660747Microvascular contributions to age-related macular degeneration (AMD): from mechanisms of choriocapillaris aging to novel interventions
Q28255630Mitochondrial variation and the risk of age-related macular degeneration across diverse populations
Q33227050Modelling the natural history of geographic atrophy in patients with age-related macular degeneration
Q34509841Monitoring of drusen and geographic atrophy area size after cataract surgery using the MD3RI tool for computer-aided contour drawing.
Q33388699Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration
Q38492049Münster age- and retina study (MARS). Association between risk factors for arteriosclerosis and age-related macular degeneration
Q26799766NLRP3 Inflammasome and Pathobiology in AMD
Q38174408Nature and nurture- genes and environment- predict onset and progression of macular degeneration.
Q34634743Neuroprotective effects of lutein in the retina
Q40649624No Sex Differences in the Frequencies of Common Single Nucleotide Polymorphisms Associated with Age-Related Macular Degeneration
Q40028590OT-674 suppresses photooxidative processes initiated by an RPE lipofuscin fluorophore.
Q36758799Obesity and eye diseases
Q39833372Ocular and systemic factors associated with diabetes mellitus in the adult population in rural and urban China. The Beijing Eye Study
Q35968037Ocular associations of metabolic syndrome
Q39349855Optical Coherence Tomographic Angiography Imaging in Age-Related Macular Degeneration
Q26748464Optical Coherence Tomography Angiography in Retinal Diseases
Q24793439Ordered subset linkage analysis supports a susceptibility locus for age-related macular degeneration on chromosome 16p12
Q41188051Overexpressed or intraperitoneally injected human transferrin prevents photoreceptor degeneration in rd10 mice
Q44584637Oxidative stress and anti-oxidative defence in patients with age-related macular degeneration
Q46824949Oxidative stress in dry age-related macular degeneration and exfoliation syndrome
Q92572396Periodontal Diseases and Age-Related Macular Degeneration: Is There a Link? A Review
Q36424457Pharmacogenetic influence of LOC387715/HTRA1 on the efficacy of bevacizumab treatment for age-related macular degeneration in a Korean population
Q46415528Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration
Q37897749Polarization sensitive optical coherence tomography in the human eye.
Q95327166Predicting conversion to wet age-related macular degeneration using deep learning
Q92059732Predictors of neovascular activity during neovascular age-related macular degeneration treatment based on optical coherence tomography angiography
Q33759162Prevalence and risk factors for age-related macular degeneration in the elderly Chinese population in south-western Taiwan: the Puzih eye study
Q40186146Prevalence and risk factors for age-related macular degeneration: Korean National Health and Nutrition Examination Survey 2008-2011.
Q38775043Prevalence of Age-Related Macular Degeneration in Slovakia and Associated Risk Factors: A Mobile Clinic-Based Cross-Sectional Epidemiological Survey
Q36294040Prevalence of age-related macular degeneration among the elderly
Q33739809Prevalence of and risk factors for age-related macular degeneration in Nepal: the Bhaktapur Retina Study
Q34728024Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration
Q34491498Prevention of age-related macular degeneration
Q36894556Progress in defining the molecular biology of age related macular degeneration
Q37407570Progression Rate From Intermediate to Advanced Age-Related Macular Degeneration Is Correlated With the Number of Risk Alleles at the CFH Locus
Q33996503Progression of geographic atrophy and genotype in age-related macular degeneration
Q30543909Quantitative fundus autofluorescence in healthy eyes.
Q34001750R102G polymorphism of the C3 gene associated with exudative age-related macular degeneration in a French population
Q34646882Race- and sex-related differences in retinal thickness and foveal pit morphology.
Q34449898Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration.
Q36377333Recent advances in the management of dry age-related macular degeneration: A review
Q41532061Recent developments in age-related macular degeneration: a review.
Q35112876Refractive error and risk of early or late age-related macular degeneration: a systematic review and meta-analysis
Q44294059Refractive error and smoking habits in exudative age-related macular degeneration in a hospital-based setting
Q39909122Refractive error, ocular and general parameters and ophthalmic diseases. The Beijing Eye Study
Q35740328Regulation of age-related macular degeneration-like pathology by complement factor H.
Q99562754Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration: Correlation with Macular Function
Q54714141Retinal blood flow velocity in patients with age-related macular degeneration.
Q42963793Retinal degeneration increases susceptibility to myopia in mice
Q38725575Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration.
Q37039797Review of genetics in age related macular degeneration.
Q38174238Review of the role of refined dietary sugars (fructose and glucose) in the genesis of retinal disease
Q38828895Risk factors and biomarkers of age-related macular degeneration
Q34084938Risk factors associated with age-related nuclear and cortical cataract : a case-control study in the Age-Related Eye Disease Study, AREDS Report No. 5.
Q35590853Risk factors for age related maculopathy in a Japanese population: the Hisayama study
Q33720834Risk factors for age-related maculopathy
Q39624600Risk factors for exudative age-related macular degeneration in a large French case-control study
Q89888023Risk factors for progression of age-related macular degeneration
Q24554181Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19
Q34491990Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25.
Q37111954Role of ocular melanin in ophthalmic physiology and pathology
Q37612307Role of statins in the development and progression of age-related macular degeneration.
Q89702866Sensitivity and Specificity of OCT Angiography to Detect Choroidal Neovascularization
Q35761464Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation
Q34449581Smoking and age-related macular degeneration: a review of association.
Q34394380Smoking and age-related macular degeneration: review and update
Q42000152Smoking and choroidal thickness in patients over 65 with early-atrophic age-related macular degeneration and normals
Q35230959Smoking, antioxidant supplementation and dietary intakes among older adults with age-related macular degeneration over 10 years
Q37013472Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications
Q44158875Statin use and the risk of age related macular degeneration in a large health organization in Israel
Q34021032Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration
Q36350410Suggestive association between PLA2G12A single nucleotide polymorphism rs2285714 and response to anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration.
Q24202631Surgery for cataracts in people with age-related macular degeneration
Q24241331Surgery for cataracts in people with age-related macular degeneration
Q30235923Surgery for cataracts in people with age-related macular degeneration.
Q38043013Susceptibility genes and pharmacogenetics in ocular inflammatory disorders
Q36350405Susceptibility to advanced age-related macular degeneration and alleles of complement factor H, complement factor B, complement component 2, complement component 3, and age-related maculopathy susceptibility 2 genes in a Mexican population.
Q34657946Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition
Q38914781Systematic Functional Testing of Rare Variants: Contributions of CFI to Age-Related Macular Degeneration
Q37365352Systems Biology Profiling of AMD on the Basis of Gene Expression
Q36023209Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks
Q34653094The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17
Q36315753The Association of Statin Use with Age-Related Macular Degeneration Progression: The Age-Related Eye Disease Study 2 Report Number 9
Q37030323The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples
Q24678569The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples
Q37406856The Royal College of Ophthalmologists Guidelines on AMD: Executive Summary
Q37457180The Royal College of Ophthalmologists' National Ophthalmology Database Study of cataract surgery: report 2, relationships of axial length with ocular copathology, preoperative visual acuity, and posterior capsule rupture
Q60907321The association between socioeconomic status and visual disability among older adults in China
Q44399930The association of cardiovascular disease with the long-term incidence of age-related maculopathy
Q45905000The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study.
Q38077553The immunological basis of degenerative diseases of the eye.
Q37678798The molecular genetic basis of age-related macular degeneration: an overview
Q39024579The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target
Q35593582The relation between C reactive protein and age related macular degeneration in the Cardiovascular Health Study
Q74138286The relation of socioeconomic factors to the incidence of early age-related maculopathy: the Beaver Dam eye study
Q44548607The relationship between iris color, hair color, and skin sun sensitivity and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study
Q33914613The relationship of major American dietary patterns to age-related macular degeneration
Q47112476The retina/RPE proteome in chick myopia and hyperopia models: Commonalities with inherited and age-related ocular pathologies
Q92360633The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective
Q36405906The role of inflammation in the pathogenesis of age-related macular degeneration
Q24802193The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: a review based on controversial evidence
Q42132169The vitreomacular interface in different types of age-related macular degeneration.
Q35530361Thyroid function and age-related macular degeneration: a prospective population-based cohort study--the Rotterdam Study
Q35530507Thyroid function: a new road to understanding age-related macular degeneration?
Q33950814Toll-like receptor polymorphisms and age-related macular degeneration: replication in three case-control samples
Q57838890Transplantation in the treatment of age-related macular degeneration: past, present and future directions
Q36697237Unfolding the Therapeutic Potential of Chemical Chaperones for Age-related Macular Degeneration
Q36311846Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration
Q37045695Use of lipid-lowering agents for the prevention of age-related macular degeneration: a meta-analysis of observational studies
Q37545004VEGF regulates local inhibitory complement proteins in the eye and kidney.
Q37834016Vascular endothelial growth factors in retinal and choroidal neovascular diseases
Q37590193Visual impairment and blindness: an overview of prevalence and causes in Brazil
Q37715254Visualization of Dietary Patterns and Their Associations With Age-Related Macular Degeneration
Q34786173Vitamin D status and early age-related macular degeneration in postmenopausal women
Q37222581Whole exome sequencing of extreme age-related macular degeneration phenotypes
Q36171917Wnt signaling in age-related macular degeneration: human macular tissue and mouse model
Q39039293Y402H polymorphism in complement factor H and age-related macular degeneration in the Tunisian population
Q33508828rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration
Q37421203{omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study

Search more.